Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2007

Feb 28, 2007

29777_dirs_2007-02-28_ce28134f-d8c2-4d56-82b0-6e178466dc57.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-02-26

Reporting Person: NEMMERS JOSEPH M (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-02-26 Common Shares without par value M 1954 $34.7727 Acquired 118553 Direct
2007-02-26 Common Shares without par value M 1393 $33.2314 Acquired 119946 Direct
2007-02-26 Common Shares without par value M 14515 $36.3985 Acquired 134461 Direct
2007-02-26 Common Shares without par value F 14034 $53.59 Disposed 120427 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-02-26 Option (right to buy) $34.7727 M 1954 Disposed 2008-02-12 common shares (1954) Direct
2007-02-26 Option (right to buy) $33.2314 M 1393 Disposed 2013-02-13 common shares (1393) Direct
2007-02-26 Option (right to buy) $36.3985 M 14515 Disposed 2012-06-27 common shares (14515) Direct
2007-02-26 Option (right to buy) $53.59 A 1267 Acquired 2008-02-12 common shares (1267) Direct
2007-02-26 Option (right to buy) $53.59 A 1072 Acquired 2013-02-13 common shares (1072) Direct
2007-02-26 Option (right to buy) $53.59 A 11695 Acquired 2012-06-27 common shares (11695) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares without par value 11178 Indirect
Common Shares without par value 357 Indirect
Common Shares without par value 300 Indirect
Common Shares without par value 293 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2007.

F2: Reporting person disclaims beneficial ownership of all securities held by his sons.

F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.